|
1
|
Rekhtman N: Neuroendocrine tumors of the
lung: An update. Arch Pathol Lab Med. 134:1628–1638. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans
DB: One hundred years after ‘carcinoid’: epidemiology of and
prognostic factors for neuroendocrine tumors in 35,825 cases in the
United States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang P, Allen MS, Aubry MC, Wampfler JA,
Marks RS, Edell ES, Thibodeau S, Adjei AA, Jett J and Deschamps C:
Clinical features of 5,628 primary lung cancer patients: Experience
at Mayo Clinic from 1997 to 2003. Chest. 128:452–462. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ettinger DS, Wood DE, Aisner DL, Akerley
W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ,
Dobelbower M, et al: Non-small cell lung cancer, version 5.2017,
NCCN clinical practice guidelines in oncology. J Natl Compr Canc
Netw. 15:504–535. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
U.S. Department of Health and Human
Services, . The health consequences of smoking-50 years of
progress: A report of the surgeon general. Atlanta, GA: U.S.
Department of Health and Human Services, Centers for Disease
Control and Prevention, National Center for Chronic Disease
Prevention and Health Promotion, Office on Smoking and Health;
2014
|
|
7
|
Amin MB, Greene FL, Edge SB, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC staging manual. 8th edition. Springer
International Publishing; New York, NY: pp. 1–1024. 2017
|
|
8
|
Cao C, Yan TD, Kennedy C, Hendel N, Bannon
PG and McCaughan BC: Bronchopulmonary carcinoid tumors: Long-term
outcomes after resection. Ann Thorac Surg. 91:339–343. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skuladottir H, Hirsch FR, Hansen HH and
Olsen JH: Pulmonary neuroendocrine tumors: Incidence and prognosis
of histological subtypes. A population-based study in Denmark. Lung
Cancer. 37:127–135. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stolz A, Harustiak T, Simonek J, Schutzner
J, Polanecky O, Burkert J and Lischke R: Long-term outcomes and
prognostic factors of patients with pulmonary carcinoid tumors.
Neoplasma. 62:478–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Froudarakis M, Fournel P, Burgard G,
Bouros D, Boucheron S, Siafakas NM and Emonot A: Bronchial
carcinoids. A review of 22 cases. Oncology. 53:153–158. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fink G, Krelbaum T, Yellin A, Bendayan D,
Saute M, Glazer M and Kramer MR: Pulmonary carcinoid: Presentation,
diagnosis, and outcome in 142 cases in Israel and review of 640
cases from the literature. Chest. 119:1647–1651. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beasley MB, Thunnissen FB, Brambilla E,
Hasleton P, Steele R, Hammar SP, Colby TV, Sheppard M, Shimosato Y,
Koss MN, et al: Pulmonary atypical carcinoid: Predictors of
survival in 106 cases. Hum Pathol. 31:1255–1265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martini N, Zaman MB, Bains MS, Burt ME,
McCormack PM, Rusch VW and Ginsberg RJ: Treatment and prognosis in
bronchial carcinoids involving regional lymph nodes. J Thorac
Cardiovasc Surg. 107:1–7. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yendamuri S, Gold D, Jayaprakash V, Dexter
E, Nwogu C and Demmy T: Is sublobar resection sufficient for
carcinoid tumors? Ann Thorac Surg. 92:1774–1779. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lou F, Sarkaria I, Pietanza C, Travis W,
Roh MS, Sica G, Healy D, Rusch V and Huang J: Recurrence of
pulmonary carcinoid tumors after resection: Implications for
postoperative surveillance. Ann Thorac Surg. 96:1156–1162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kneuertz PJ, Kamel MK, Stiles BM, Lee BE,
Rahouma M, Harrison SW, Altorki NK and Port JL: Incidence and
prognostic significance of carcinoid lymph node metastases. Ann
Thorac Surg. 106:981–988. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johnson R, Trocha S, McLawhorn M, Worley
M, Wheeler G, Thompson L, Schisler N, Schammel D, Schammel C,
Stephenson J and Bolton W: Histology, not lymph node involvement,
predicts long-term survival in bronchopulmonary carcinoids. Am
Surg. 77:1669–1674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cardillo G, Sera F, Di Martino M, Graziano
P, Giunti R, Carbone L, Facciolo F and Martelli M: Bronchial
carcinoid tumors: Nodal status and long-term survival after
resection. Ann Thorac Surg. 77:1781–1785. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okereke IC, Taber AM, Griffith RC and Ng
TT: Outcomes after surgical resection of pulmonary carcinoid
tumors. J Cardiothorac Surg. 11:352016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramirez RA, Beyer DT, Diebold AE, Voros
BA, Chester MM, Wang YZ, Boudreaux JP, Woltering EA, Uhlhorn AP,
Ryan P, et al: Prognostic factors in typical and atypical pulmonary
carcinoids. Ochsner J. 17:335–340. 2017.PubMed/NCBI
|
|
22
|
Chen X, Pang Z, Wang Y, Bie F, Zeng Y,
Wang G and Du J: The role of surgery for atypical bronchopulmonary
carcinoid tumor: Development and validation of a model based on
surveillance, epidemiology, and end results (SEER) database. Lung
Cancer. 139:94–102. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Walters SL, Canavan ME, Salazar MC, Resio
BJ, Blasberg JD, Mase V and Boffa DJ: A national study of
surgically managed atypical pulmonary carcinoid tumors. Ann Thorac
Surg. 112:921–927. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Canizares MA, Matilla JM, Cueto A, Algar
J, Muguruza I, Moreno-Mata N, Moreno-Balsalobre R, Guijarro R,
Arrabal R, Garcia-Fontan E, et al: Atypical carcinoid tumours of
the lung: Prognostic factors and patterns of recurrence. Thorax.
69:648–653. 2014. View Article : Google Scholar : PubMed/NCBI
|
